Cerus Corporation: Strong Q1 Results Validate The Turnaround Thesis
Cerus Corporation (CERS) Q1 2026 Earnings Call Transcript
Cerus Corporation Announces First Quarter 2026 Financial Results
Cerus Corporation Announces New, Four-Year Supply Agreement with French Blood Establishment for INTERCEPT Blood System
Critical Analysis: Akanda (NASDAQ:AKAN) and Cerus (NASDAQ:CERS)
Cerus Corporation to Release First Quarter 2026 Financial Results on April 30, 2026
Kevin Dennis Green Sells 127,544 Shares of Cerus (NASDAQ:CERS) Stock
Vivek Jayaraman Sells 165,200 Shares of Cerus (NASDAQ:CERS) Stock
Chrystal Jensen Sells 113,008 Shares of Cerus (NASDAQ:CERS) Stock
Cerus Appoints Vivek Jayaraman as President and Chief Executive Officer
Cerus Details INTERCEPT Growth Plan, BCA Deal Upside and 2026 RBC Milestones at TD Cowen Conference
Cerus's Record 2025 Sets It Up For Another Leg Higher
Cerus Corporation (CERS) Q4 2025 Earnings Call Transcript
Cerus Corporation Announces Full-Year and Fourth Quarter 2025 Financial Results
Cerus (NASDAQ:CERS) Stock Price Crosses Above 200-Day Moving Average – Should You Sell?
Cerus Corporation to Participate in the TD Cowen 46th Annual Health Care Conference
Cerus Corporation to Release Fourth Quarter and Full-Year 2025 Financial Results on March 2, 2026
DRK Blood Donation Service Baden-Württemberg – Hessen Starts INITIATE Study to Evaluate Pathogen-Inactivated Platelet Concentrates Treated with Cerus' INTERCEPT™ Blood System in Routine Clinical Practice
Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2025 Product Revenue and Provides Outlook
Cerus Corporation Announces Group Purchasing Agreement with Blood Centers of America
Cerus: IFC Growth And RBC Optionality
Connor Clark & Lunn Investment Management Ltd. Acquires 97,592 Shares of Cerus Corporation $CERS
Cerus Corporation (CERS) Q3 2025 Earnings Call Transcript
Cerus Corporation Announces Record Results for Third Quarter 2025 and Raises Full Year 2025 Product Revenue Guidance
Cerus Corporation Announces Abstracts and Industry Workshop on IFC at the 2025 AABB Annual Meeting
Cerus Corporation to Release Third Quarter 2025 Financial Results on November 6, 2025
The German National Blood Advisory Committee Issues Formal Recommendation for Improving the Safety of Platelet Transfusions
Cerus Corporation (CERS) Q2 2025 Earnings Call Transcript
Cerus Corporation Announces Second Quarter 2025 Financial Results
Cerus Corporation to Release Second Quarter 2025 Financial Results on August 5, 2025
Cerus Corporation Announces Additional Department of Defense Award to Advance Care for Major Hemorrhage in Traumatic Injury
Cerus Corporation Provides INTERCEPT Red Blood Cell CE Mark Application Update
Cerus Corporation Celebrates World Blood Donor Day 2025
Cerus Corporation to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference 2025
Cerus Corporation Presents Clinical Data for INTERCEPT Blood System at the 35th Regional International Society of Blood Transfusion Congress in Milan
Cerus Corporation Announces Multiple In-Country Regulatory Approvals for INT200 – Next-Generation INTERCEPT Illumination Device
Cerus Corporation (CERS) Q1 2025 Earnings Call Transcript
Cerus (CERS) Reports Q1 Loss, Tops Revenue Estimates
Cerus Corporation Announces First Quarter 2025 Financial Results
Cerus Corporation to Release First Quarter 2025 Financial Results on May 1, 2025
Cerus Corporation Announces Receipt of CE Mark for Next-Generation INTERCEPT Illumination Device (INT200)
Cerus Corporation (CERS) Q4 2024 Earnings Call Transcript
Cerus Corporation to Release Fourth Quarter and Full-Year 2024 Financial Results on February 20, 2025
Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2024 Product Revenue and Provides Business Update
Cerus Corporation (CERS) Q3 2024 Earnings Call Transcript
Cerus (CERS) Reports Q3 Loss, Tops Revenue Estimates
Cerus Corporation Announces Third Quarter 2024 Financial Results
Cerus Corporation Announces Workshop and Abstracts at the 2024 AABB Annual Meeting
Cerus Corporation to Release Third Quarter 2024 Financial Results on October 30, 2024